IMCD Acquires Trichem to Bolster Pharma Footprint in India
Deal News | Jun 26, 2025 | Globenewswire
IMCD N.V., a prominent global distributor of specialty chemicals and ingredients, has acquired the entirety of shares in Trichem Healthcare Private Limited, Trichem Lifesciences Limited, and Chemistry & Health FZ LLC. Trichem, established in 1998 and headquartered in Mumbai, India, has a notable reputation in the healthcare sector, primarily dealing with active pharmaceutical ingredients, pharmaceutical intermediates, and formulation solutions. The company caters to the demanding pharmaceutical markets in India and generates annual revenue of approximately INR 1.7 billion. For IMCD, this acquisition not only strengthens its presence in India's burgeoning pharmaceutical sector but also enhances its portfolio in active pharmaceutical ingredients. The move is expected to have considerable benefits, given India's status as a global supplier of generic drugs. IMCD's Managing Director for India, Narendra Varde, highlighted the strategic enhancement this acquisition brings, particularly in life sciences. Chetan Jain, Founder of Trichem, expressed confidence in the potential value creation this merger with IMCD's extensive global network will deliver. IMCD is headquartered in Rotterdam, The Netherlands, and is publicly traded on Euronext Amsterdam.
Sectors
- Pharmaceuticals
- Specialty Chemicals
Geography
- India – Trichem is headquartered in Mumbai, India, and the acquisition enhances IMCD's presence in the Indian pharmaceutical market.
- Netherlands – IMCD is based in Rotterdam, The Netherlands, and is executing the acquisition from this geographic standpoint.
Industry
- Pharmaceuticals – The article focuses on the acquisition of Trichem, which is involved in the pharmaceutical sector, specifically in active pharmaceutical ingredients and formulation solutions.
- Specialty Chemicals – IMCD is a distributor and formulator of specialty chemicals, which is relevant to both its core business and the acquisition target's industry focus.
Financials
- INR 1.7 billion – Trichem's annual revenue for the financial year ended 31 March 2025, equivalent to approximately EUR 18 million.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| IMCD N.V. | Bidding Company | Company | A global leader in the distribution and formulation of speciality chemicals and ingredients, based in the Netherlands. |
| Trichem Healthcare Private Limited | Target Company | Company | An Indian company involved in the pharmaceutical sector, known for its active pharmaceutical ingredients and formulation solutions. |
| Trichem Lifesciences Limited | Part of Target Company | Company | Associated with Trichem Healthcare in the acquisition. |
| Chemistry & Health FZ LLC | Part of Target Company | Company | Involved in the acquisition along with Trichem Healthcare and Trichem Lifesciences. |
| Chetan Jain | Founder and Promoter of Trichem Group | People | Founder of Trichem, sharing his vision and support for the acquisition. |